SCHEMBL6914964

SCHEMBL6914964

COc1ccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)nc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.53
ITGA2B P08514 1/20 0.53
PPARA Q07869 7/20 0.52
PPARG P37231 6/20 0.52
ITGA4 P13612 2/20 0.48
ITGB7 P26010 2/20 0.48
PTPN1 P18031 3/20 0.48
ACE P12821 1/20 0.47
SCN9A Q15858 1/20 0.43
PPARD Q03181 2/20 0.42
HDAC8 Q9BY41 1/20 0.41
CTSS P25774 3/20 0.41
CTSK P43235 2/20 0.41
ITGB1 P05556 1/20 0.41
ITGAV P06756 1/20 0.41
ITGA5 P08648 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23963236 0.91 PPARG (0.44) ITGB3ITGA2BPPARAPPARGITGA4
SCHEMBL23963101 0.91 PPARG (0.44) ITGB3ITGA2BPPARAPPARGITGA4
SCHEMBL12158621 0.87 ITGB3 (0.58) ITGB3ITGA2BPPARAPPARGITGA4
SCHEMBL12158601 0.87 ITGB3 (0.58) ITGB3ITGA2BPPARAPPARGITGA4
SCHEMBL1350409 0.85 PTPN1 (0.57) ITGB3ITGA2BPPARAPPARGPTPN1
SCHEMBL1350878 0.85 PTPN1 (0.57) ITGB3ITGA2BPPARAPPARGPTPN1
SCHEMBL11915445 0.85 PPARA (0.50) ITGB3ITGA2BPPARAPPARGITGA4
SCHEMBL4196625 0.85 CTSS (0.49) ITGB3ITGA2BPPARAPPARGITGA4
SCHEMBL20422453 0.85 CTSS (0.49) ITGB3ITGA2BPPARAPPARGITGA4
SCHEMBL11915449 0.85 PPARA (0.50) ITGB3ITGA2BPPARAPPARGITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825200-B1 TREATING, PROLONGING, OR EXTENDING THE ONSET OF ORGAN REJECTION IN A HUMAN DURING OR AFTER ORGAN TRANSPLANTATION IN A HUMAN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
EP-1226159-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-31 EP disclosed
WO-2001032690-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-10 WO disclosed